Published online 19 March 2001. doi:10.1083/jcb.152.6.1145
© The Rockefeller University Press,
0021-9525/2001//1145 $5.00
The Journal of Cell Biology, Volume 152, Number 6,
, 2001 1145-1158
Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-Type Plasminogen Activator Receptor Binding to Vitronectin
Lars Kjøllera and
Alan Halla,b
a Medical Research Council Laboratory for Molecular Cell Biology, Cancer Research Campaign Oncogene and Signal Transduction Group
b Department of Biochemistry, University College London, London WC1E 6BT, United Kingdom
MRC Laboratory for Molecular Cell Biology, University College London, Gower St., WC1E 6BT London, UK.44-20-7679-780544-20-7679-7909
alan.hall{at}ucl.ac.uk
The urokinase-type plasminogen activator receptor (uPAR) is involved in the regulation of cell motility in a variety of cell types. We show here that expression of human uPAR in growing murine fibroblasts leads to a dramatic reorganization of the actin cytoskeleton. uPAR expression induces multiple rapidly advancing protrusions that resemble the leading edge of migrating cells. The cytoskeletal changes are independent of uPA and activation of the RGD-binding activity of integrins but require uPAR binding to vitronectin (VN). The actin reorganization is blocked by coexpression of dominant negative versions of either Rac (N17Rac) or p130Cas, but not by inhibitors of Cdc42 or Rho, and is accompanied by a Rac-dependent increase in cell motility. In addition, a fourfold increase in the level of activated Rac is induced by uPAR expression. We conclude that uPAR interacts with VN both to initiate a p130Cas/Rac-dependent signaling pathway leading to actin reorganization and increased cell motility and to act as an adhesion receptor required for these responses. This mechanism may play a role in uPAR-mediated regulation of cell motility at sites where VN and uPAR are co-expressed, such as malignant tumors.
Key Words: cell migration Rho family GTPases vitronectin cytoskeleton urokinase-type plasminogen activator receptor
© 2001 The Rockefeller University Press
L. Kjøller's present address is The Finsen Laboratory, Rigshospitalet, Strandboulevarden 49, Bldg. 7.2., DK-2100 Copenhagen Ø, Denmark. Tel.: 45-3545-5615. Fax: 45-3538-5450.
Abbreviations used in this paper: DFP, diisopropylfluorophosphate; ERK, extracellular signal–regulated kinase; FN, fibronectin; GFP, green fluorescent protein; GST, glutathione S-transferase; PAK, p21-activated kinase; PI3K, phosphatidylinositol 3-kinase; PIPLC, phosphatidylinositol-specific PLC; uPA, urokinase-type plasminogen activator; uPAR, uPA receptor; VN, vitronectin; WASP, Wiskott-Aldrich syndrome protein.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
Jo, M., Lester, R. D., Montel, V., Eastman, B., Takimoto, S., Gonias, S. L.
(2009). Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling. J. Biol. Chem.
284: 22825-22833
[Abstract]
[Full Text]
-
Zhu, S., Gladson, C. L., White, K. E., Ding, Q., Stewart, J. Jr., Jin, T. H., Chapman, H. A. Jr., Olman, M. A.
(2009). Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins. Am. J. Physiol. Lung Cell. Mol. Physiol.
297: L97-L108
[Abstract]
[Full Text]
-
Jo, M., Takimoto, S., Montel, V., Gonias, S. L.
(2009). The Urokinase Receptor Promotes Cancer Metastasis Independently of Urokinase-Type Plasminogen Activator in Mice. Am. J. Pathol.
175: 190-200
[Abstract]
[Full Text]
-
D'mello, V., Singh, S., Wu, Y., Birge, R. B.
(2009). The Urokinase Plasminogen Activator Receptor Promotes Efferocytosis of Apoptotic Cells. J. Biol. Chem.
284: 17030-17038
[Abstract]
[Full Text]
-
Prager, G. W., Mihaly, J., Brunner, P. M., Koshelnick, Y., Hoyer-Hansen, G., Binder, B. R.
(2009). Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Blood
113: 1383-1390
[Abstract]
[Full Text]
-
Williams, S. A., Schwarzbauer, J. E.
(2009). A Shared Mechanism of Adhesion Modulation for Tenascin-C and Fibulin-1. Mol. Biol. Cell
20: 1141-1149
[Abstract]
[Full Text]
-
Smith, H. W., Marra, P., Marshall, C. J.
(2008). uPAR promotes formation of the p130Cas-Crk complex to activate Rac through DOCK180. JCB
182: 777-790
[Abstract]
[Full Text]
-
Hillig, T., Engelholm, L. H., Ingvarsen, S., Madsen, D. H., Gardsvoll, H., Larsen, J. K., Ploug, M., Dano, K., Kjoller, L., Behrendt, N.
(2008). A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor. J. Biol. Chem.
283: 15217-15223
[Abstract]
[Full Text]
-
Elia, C., Cassol, E., Sidenius, N., Blasi, F., Castagna, A., Poli, G., Alfano, M.
(2007). Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J. Leukoc. Biol.
82: 1212-1220
[Abstract]
[Full Text]
-
Lester, R. D., Jo, M., Montel, V., Takimoto, S., Gonias, S. L.
(2007). uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells. JCB
178: 425-436
[Abstract]
[Full Text]
-
Madsen, C. D., Ferraris, G. M. S., Andolfo, A., Cunningham, O., Sidenius, N.
(2007). uPAR-induced cell adhesion and migration: vitronectin provides the key. JCB
177: 927-939
[Abstract]
[Full Text]
-
Gardsvoll, H., Ploug, M.
(2007). Mapping of the Vitronectin-binding Site on the Urokinase Receptor: INVOLVEMENT OF A COHERENT RECEPTOR INTERFACE CONSISTING OF RESIDUES FROM BOTH DOMAIN I AND THE FLANKING INTERDOMAIN LINKER REGION. J. Biol. Chem.
282: 13561-13572
[Abstract]
[Full Text]
-
Tscharntke, M., Pofahl, R., Chrostek-Grashoff, A., Smyth, N., Niessen, C., Niemann, C., Hartwig, B., Herzog, V., Klein, H. W., Krieg, T., Brakebusch, C., Haase, I.
(2007). Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1. J. Cell Sci.
120: 1480-1490
[Abstract]
[Full Text]
-
Wei, Y., Tang, C.-H., Kim, Y., Robillard, L., Zhang, F., Kugler, M. C., Chapman, H. A.
(2007). Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells. J. Biol. Chem.
282: 3929-3939
[Abstract]
[Full Text]
-
Bujo, H., Saito, Y.
(2006). Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family. Arterioscler. Thromb. Vasc. Bio.
26: 1246-1252
[Abstract]
[Full Text]
-
Silva, J., Dasgupta, S., Wang, G., Krishnamurthy, K., Ritter, E., Bieberich, E.
(2006). Lipids isolated from bone induce the migration of human breast cancer cells. J. Lipid Res.
47: 724-733
[Abstract]
[Full Text]
-
Kuo, J.-C., Wang, W.-J., Yao, C.-C., Wu, P.-R., Chen, R.-H.
(2006). The tumor suppressor DAPK inhibits cell motility by blocking the integrin-mediated polarity pathway.. JCB
172: 619-631
[Abstract]
[Full Text]
-
Bauer, T. W., Liu, W., Fan, F., Camp, E. R., Yang, A., Somcio, R. J., Bucana, C. D., Callahan, J., Parry, G. C., Evans, D. B., Boyd, D. D., Mazar, A. P., Ellis, L. M.
(2005). Targeting of Urokinase Plasminogen Activator Receptor in Human Pancreatic Carcinoma Cells Inhibits c-Met- and Insulin-like Growth Factor-I Receptor-Mediated Migration and Invasion and Orthotopic Tumor Growth in Mice. Cancer Res.
65: 7775-7781
[Abstract]
[Full Text]
-
Degryse, B., Resnati, M., Czekay, R.-P., Loskutoff, D. J., Blasi, F.
(2005). Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR. J. Biol. Chem.
280: 24792-24803
[Abstract]
[Full Text]
-
Gargiulo, L., Longanesi-Cattani, I., Bifulco, K., Franco, P., Raiola, R., Campiglia, P., Grieco, P., Peluso, G., Stoppelli, M. P., Carriero, M. V.
(2005). Cross-talk between fMLP and Vitronectin Receptors Triggered by Urokinase Receptor-derived SRSRY Peptide. J. Biol. Chem.
280: 25225-25232
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., Marozkina, N., Amin, T. J., Silva, C. M., Parsons, S. J., Gonias, S. L.
(2005). Dynamic Assembly of the Urokinase-type Plasminogen Activator Signaling Receptor Complex Determines the Mitogenic Activity of Urokinase-type Plasminogen Activator. J. Biol. Chem.
280: 17449-17457
[Abstract]
[Full Text]
-
Bass, R., Werner, F., Odintsova, E., Sugiura, T., Berditchevski, F., Ellis, V.
(2005). Regulation of Urokinase Receptor Proteolytic Function by the Tetraspanin CD82. J. Biol. Chem.
280: 14811-14818
[Abstract]
[Full Text]
-
Li, H., Ye, X., Mahanivong, C., Bian, D., Chun, J., Huang, S.
(2005). Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells. J. Biol. Chem.
280: 10564-10571
[Abstract]
[Full Text]
-
Bernstein, A. M., Greenberg, R. S., Taliana, L., Masur, S. K.
(2004). Urokinase Anchors uPAR to the Actin Cytoskeleton. IOVS
45: 2967-2977
[Abstract]
[Full Text]
-
Cao, D. J., Guo, Y.-L., Colman, R. W.
(2004). Urokinase-Type Plasminogen Activator Receptor Is Involved in Mediating the Apoptotic Effect of Cleaved High Molecular Weight Kininogen in Human Endothelial Cells. Circ. Res.
94: 1227-1234
[Abstract]
[Full Text]
-
Monaghan, E., Gueorguiev, V., Wilkins-Port, C., McKeown-Longo, P. J.
(2004). The Receptor for Urokinase-type Plasminogen Activator Regulates Fibronectin Matrix Assembly in Human Skin Fibroblasts. J. Biol. Chem.
279: 1400-1407
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., Wu, L., Gonias, S. L.
(2003). Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling. J. Biol. Chem.
278: 46692-46698
[Abstract]
[Full Text]
-
Alfano, M., Sidenius, N., Blasi, F., Poli, G.
(2003). The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection. J. Leukoc. Biol.
74: 750-756
[Abstract]
[Full Text]
-
Carton, I., Hermans, D., Eggermont, J.
(2003). Hypotonicity induces membrane protrusions and actin remodeling via activation of small GTPases Rac and Cdc42 in Rat-1 fibroblasts. Am. J. Physiol. Cell Physiol.
285: C935-C944
[Abstract]
[Full Text]
-
Sturge, J., Wienke, D., East, L., Jones, G. E., Isacke, C. M.
(2003). GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis. JCB
162: 789-794
[Abstract]
[Full Text]
-
Stefansson, S., Lawrence, D. A.
(2003). Old Dogs and New Tricks, Proteases, Inhibitors, and Cell Migration. Sci Signal
2003: pe24-pe24
[Abstract]
[Full Text]
-
Aguirre-Ghiso, J. A., Estrada, Y., Liu, D., Ossowski, L.
(2003). ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK. Cancer Res.
63: 1684-1695
[Abstract]
[Full Text]
-
Engelholm, L. H., List, K., Netzel-Arnett, S., Cukierman, E., Mitola, D. J., Aaronson, H., Kjoller, L., Larsen, J. K., Yamada, K. M., Strickland, D. K., Holmbeck, K., Dano, K., Birkedal-Hansen, H., Behrendt, N., Bugge, T. H.
(2003). uPARAP/Endo180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion. JCB
160: 1009-1015
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., O'Donnell, D. M., Gonias, S. L.
(2003). Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor. J. Biol. Chem.
278: 1642-1646
[Abstract]
[Full Text]
-
Ma, Z., Thomas, K. S., Webb, D. J., Moravec, R., Salicioni, A. M., Mars, W. M., Gonias, S. L.
(2002). Regulation of Rac1 activation by the low density lipoprotein receptor-related protein. JCB
159: 1061-1070
[Abstract]
[Full Text]
-
Edme, N., Downward, J., Thiery, J.-P., Boyer, B.
(2002). Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J. Cell Sci.
115: 2591-2601
[Abstract]
[Full Text]
-
Jo, M., Thomas, K. S., Somlyo, A. V., Somlyo, A. P., Gonias, S. L.
(2002). Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell Migration. J. Biol. Chem.
277: 12479-12485
[Abstract]
[Full Text]
-
Sturge, J., Hamelin, J., Jones, G. E.
(2002). N-WASP activation by a {beta}1-integrin-dependent mechanism supports PI3K-independent chemotaxis stimulated by urokinase-type plasminogen activator. J. Cell Sci.
115: 699-711
[Abstract]
[Full Text]